Ibio Market Cap from 2010 to 2024
| IBIO Stock | USD 2.54 0.02 0.78% |
Market Cap | First Reported 2010-12-31 | Previous Quarter 6.9 M | Current Value 6.2 M | Quarterly Volatility 431.7 K |
Check Ibio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ibio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 163.4 K or Total Revenue of 213.8 K, as well as many indicators such as Price To Sales Ratio of 37.39, Dividend Yield of 0.0662 or PTB Ratio of 0.34. Ibio financial statements analysis is a perfect complement when working with Ibio Valuation or Volatility modules.
Ibio | Market Cap |
Pair Trading with Ibio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ibio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will appreciate offsetting losses from the drop in the long position's value.Moving together with Ibio Stock
Moving against Ibio Stock
| 0.82 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.73 | INKT | Mink Therapeutics | PairCorr |
| 0.72 | RGNX | Regenxbio | PairCorr |
| 0.65 | NKTX | Nkarta Inc | PairCorr |
| 0.61 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to Ibio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ibio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ibio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ibio Inc to buy it.
The correlation of Ibio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ibio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ibio Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ibio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Ibio Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share 0.059 | Quarterly Revenue Growth (0.88) | Return On Assets (0.30) | Return On Equity (0.84) |
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.